Zinger Key Points
- Stephanie Link of Hightower names Palo Alto, a cybersecurity stock.
- Brenda Vingiello picks Vertex Pharmaceuticals Incorporated.
- China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the next trade alert free.
On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management picked CrowdStrike Holdings, Inc. CRWD.
On Wednesday, CrowdStrike announced an expansion of its partnership with Alphabet Inc's GOOG Google Cloud to enable end-to-end security for AI innovation with the company's Falcon Cloud Security platform.
Don't forget to check out our premarket coverage here
Brenda Vingiello of Sand Hill Global Advisors named Vertex Pharmaceuticals Incorporated VRTX, saying the first non-opioid pain medication will be a game changer.
Vertex Pharmaceuticals will report its first-quarter financial results on Monday, May 5, after the closing bell.
Bryn Talkington of Requisite Capital Management picked Robinhood Markets, Inc. HOOD as her final trade.
On the earnings front, Robinhood Markets will release its first quarter financial results on Wednesday, April 30, after the closing bell. Analysts expect the company to report quarterly earnings at 37 cents per share on revenue of $909.41 million.
Stephanie Link of Hightower named Palo Alto Networks, Inc. PANW, a cybersecurity stock.
Supporting her view, HSBC analyst Stephen Bersey, on Thursday, upgraded Palo Alto Networks from Reduce to Hold and announced a $156 price target.
Price Action:
- Vertex Pharmaceuticals shares fell 1.4% to close at $475.49 on Thursday.
- Robinhood shares dipped 4% to close at $40.51 during Thursday's session.
- CrowdStrike shares fell 2.5% to close at $368.61 on Thursday.
- Palo Alto Networks fell 2.8% to settle at $168.27 during Thursday's session.
Check This Out:
Image: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.